Koneksa Enrolls First Patient in LEARNS Observational Study to Remotely Measure Disease Progression Using Digital Biomarkers in Neurodegenerative Disorders
The remote measurement of disease utilizing digital biomarkers provides an opportunity to capture disease change and impacts in the context of daily living and in a more convenient fashion.
- The remote measurement of disease utilizing digital biomarkers provides an opportunity to capture disease change and impacts in the context of daily living and in a more convenient fashion.
- The remote measurement of disease utilizing digital biomarkers provides an opportunity to capture disease change and impacts in the context of daily living and in a more convenient fashion.
- The study will enroll up to 70 participants with Parkinson’s disease for the disease progression portion of the study.
- The LEARNS study represents an effort utilizing digital biomarkers to remotely measure disease progression, providing a patient-centered opportunity to capture disease changes and impacts in the context of daily living.